Lv11
60 积分 2023-03-06 加入
Chronic obstructive pulmonary disease as a double-edged sword—reshaping NSCLC immunotherapy paradigms
4天前
求助中
The Impact of Shanghai’s Comprehensive Smoke-Free Legislation on Hospital Admission and Mortality Rates for Chronic Obstructive Pulmonary Disease:An interrupted time series analysis
4天前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
7天前
已完结
Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study
9天前
已完结
Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning
23天前
已完结
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
1个月前
已完结
The expanding landscape of GLP-1 medicines
1个月前
已完结
Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
1个月前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
1个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
皖公网安备34019202002308
